Guangxi Wuzhou Zhongheng Group Co Ltd (600252) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangxi Wuzhou Zhongheng Group Co Ltd (600252) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-76.63 Million ≈ $-11.21 Million USD) by net assets (CN¥7.26 Billion ≈ $1.06 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Guangxi Wuzhou Zhongheng Group Co Ltd worth for the company's overall valuation and market capitalisation.
Guangxi Wuzhou Zhongheng Group Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Guangxi Wuzhou Zhongheng Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangxi Wuzhou Zhongheng Group Co Ltd ranked by their cash flow conversion efficiency. Explore 600252 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Procept Biorobotics Corp
NASDAQ:PRCT
|
-0.017x |
|
Corporación Interamericana de Entretenimiento S.A.B. de C.V
MX:CIEB
|
-0.085x |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
0.009x |
|
Trupanion Inc
NASDAQ:TRUP
|
0.051x |
|
Rackspace Technology Inc
NASDAQ:RXT
|
-0.004x |
|
Thinking Electronic Industrial Co Ltd
TW:2428
|
0.046x |
|
Idorsia Ltd
SW:IDIA
|
0.023x |
|
Vitec Software Group AB (publ)
ST:VIT-B
|
0.018x |
Annual Cash Flow Conversion Efficiency for Guangxi Wuzhou Zhongheng Group Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Guangxi Wuzhou Zhongheng Group Co Ltd from 1999 to 2025. View Guangxi Wuzhou Zhongheng Group Co Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.74 Billion ≈ $986.86 Million |
CN¥-18.91 Million ≈ $-2.77 Million |
-0.003x | -104.41% |
| 2024-12-31 | CN¥7.51 Billion ≈ $1.10 Billion |
CN¥477.43 Million ≈ $69.86 Million |
0.064x | +8.62% |
| 2023-12-31 | CN¥8.28 Billion ≈ $1.21 Billion |
CN¥484.10 Million ≈ $70.84 Million |
0.058x | +385.05% |
| 2022-12-31 | CN¥8.29 Billion ≈ $1.21 Billion |
CN¥-170.09 Million ≈ $-24.89 Million |
-0.021x | -132.36% |
| 2021-12-31 | CN¥8.69 Billion ≈ $1.27 Billion |
CN¥-76.74 Million ≈ $-11.23 Million |
-0.009x | -111.07% |
| 2020-12-31 | CN¥8.23 Billion ≈ $1.20 Billion |
CN¥656.62 Million ≈ $96.08 Million |
0.080x | -21.97% |
| 2019-12-31 | CN¥6.40 Billion ≈ $936.15 Million |
CN¥654.31 Million ≈ $95.75 Million |
0.102x | -28.93% |
| 2018-12-31 | CN¥5.93 Billion ≈ $867.77 Million |
CN¥853.40 Million ≈ $124.88 Million |
0.144x | -9.83% |
| 2017-12-31 | CN¥5.60 Billion ≈ $818.98 Million |
CN¥893.21 Million ≈ $130.71 Million |
0.160x | -43.17% |
| 2016-12-31 | CN¥5.33 Billion ≈ $779.28 Million |
CN¥1.50 Billion ≈ $218.86 Million |
0.281x | +377.32% |
| 2015-12-31 | CN¥4.95 Billion ≈ $725.03 Million |
CN¥291.53 Million ≈ $42.66 Million |
0.059x | -38.91% |
| 2014-12-31 | CN¥5.92 Billion ≈ $865.96 Million |
CN¥569.95 Million ≈ $83.40 Million |
0.096x | -62.41% |
| 2013-12-31 | CN¥3.69 Billion ≈ $539.83 Million |
CN¥945.10 Million ≈ $138.30 Million |
0.256x | -12.24% |
| 2012-12-31 | CN¥3.11 Billion ≈ $454.39 Million |
CN¥906.43 Million ≈ $132.64 Million |
0.292x | +255.33% |
| 2011-12-31 | CN¥2.00 Billion ≈ $292.73 Million |
CN¥-375.93 Million ≈ $-55.01 Million |
-0.188x | -231.00% |
| 2010-12-31 | CN¥1.34 Billion ≈ $195.58 Million |
CN¥191.73 Million ≈ $28.06 Million |
0.143x | +394.70% |
| 2009-12-31 | CN¥576.93 Million ≈ $84.42 Million |
CN¥-28.08 Million ≈ $-4.11 Million |
-0.049x | -137.00% |
| 2008-12-31 | CN¥451.95 Million ≈ $66.13 Million |
CN¥59.47 Million ≈ $8.70 Million |
0.132x | +33.92% |
| 2007-12-31 | CN¥414.81 Million ≈ $60.70 Million |
CN¥40.75 Million ≈ $5.96 Million |
0.098x | -82.41% |
| 2006-12-31 | CN¥356.94 Million ≈ $52.23 Million |
CN¥199.41 Million ≈ $29.18 Million |
0.559x | +283.23% |
| 2005-12-31 | CN¥385.08 Million ≈ $56.35 Million |
CN¥56.14 Million ≈ $8.21 Million |
0.146x | -51.80% |
| 2004-12-31 | CN¥476.29 Million ≈ $69.70 Million |
CN¥144.06 Million ≈ $21.08 Million |
0.302x | +207.96% |
| 2003-12-31 | CN¥438.88 Million ≈ $64.22 Million |
CN¥-122.95 Million ≈ $-17.99 Million |
-0.280x | -77.66% |
| 2002-12-31 | CN¥428.29 Million ≈ $62.67 Million |
CN¥-67.54 Million ≈ $-9.88 Million |
-0.158x | -436.43% |
| 2001-12-31 | CN¥399.28 Million ≈ $58.43 Million |
CN¥-11.74 Million ≈ $-1.72 Million |
-0.029x | +36.69% |
| 2000-12-31 | CN¥375.55 Million ≈ $54.95 Million |
CN¥-17.44 Million ≈ $-2.55 Million |
-0.046x | -113.21% |
| 1999-12-31 | CN¥148.77 Million ≈ $21.77 Million |
CN¥52.29 Million ≈ $7.65 Million |
0.351x | -- |
About Guangxi Wuzhou Zhongheng Group Co Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for … Read more